Anastrozole is a potent aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It plays a crucial role in decreasing the levels of estrogen in the body, thereby inhibiting the growth of certain types of breast tumors that require estrogen for their growth.
For a comprehensive understanding of Anastrozole’s pharmacological action, please refer to this detailed article: https://dronchessacademy.com/index.php/2026/02/22/understanding-the-pharmacological-action-of-anastrozole/
Mechanism of Action
Anastrozole works by specifically inhibiting the aromatase enzyme, which is responsible for converting androgens into estrogens in the peripheral tissues. The main pharmacological actions include:
- Estrogen Level Reduction: By blocking the aromatase enzyme, Anastrozole significantly lowers circulating estrogen levels, making it less available for estrogen-dependent tumor growth.
- Antitumor Activity: Lower estrogen levels help slow or stop the proliferation of hormone-sensitive breast cancer cells.
- Improved Survival Rates: Clinical trials have demonstrated that Anastrozole can improve overall survival rates and reduce the risk of cancer recurrence in patients with early-stage hormone receptor-positive breast cancer.
Adverse Effects
While Anastrozole is effective, it is not without side effects. Common adverse effects include:
- Hot flashes
- Nausea
- Joint pain
- Fatigue
Conclusion
Anastrozole remains a cornerstone in the management of hormone receptor-positive breast cancer. Its ability to effectively lower estrogen levels and impact tumor growth positively underscores its significance in oncological pharmacotherapy.